Home
UNCY
UNCY News

Latest Unicycive Therapeutics Inc. (UNCY) News on July 12, 2025

Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

GlobeNewswire

12 days ago

Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

MT Newswires

25 days ago

Unicycive Therapeutics to Implement 1-for-10 Reverse Stock Split

Unicycive Therapeutics, Inc. Announces Reverse Stock Split

GlobeNewswire

25 days ago

Unicycive Therapeutics, Inc. Announces Reverse Stock Split

Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m

Simply Wall St.

a month ago

Retail investors are Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) biggest owners and were hit after market cap dropped US$28m

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

MT Newswires

a month ago

Top Premarket Decliners

MT Newswires

a month ago

Unicycive Says US FDA Inspection Reveals Manufacturing Deficiencies for Oxylanthanum Carbonate Drug Candidate; Shares Down

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

GlobeNewswire

a month ago

Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Unicycive Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

2 months ago

Unicycive Therapeutics to Present at Upcoming Investor Conferences

Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders

GlobeNewswire

2 months ago

Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders

Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

2 months ago

Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long

Simply Wall St.

2 months ago

Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long

MT Newswires

3 months ago

Guggenheim Initiates Unicycive Therapeutics at Buy With $6 Price Target

Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis

GlobeNewswire

3 months ago

Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis

Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

3 months ago

Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update

Unicycive to Highlight Patient Reported Outcomes Data at Upcoming Medical Meetings Showing Oxylanthanum Carbonate Reduced Pill Burden and Improved Adherence in Treatment of Hyperphosphatemia

GlobeNewswire

4 months ago

Unicycive to Highlight Patient Reported Outcomes Data at Upcoming Medical Meetings Showing Oxylanthanum Carbonate Reduced Pill Burden and Improved Adherence in Treatment of Hyperphosphatemia

Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360

GlobeNewswire

5 months ago

Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360

Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science

GlobeNewswire

5 months ago

Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in the Journal of Nephrological Science

Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation

Simply Wall St.

5 months ago

Here's Why We're Watching Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Situation

Unicycive Therapeutics Announces Publication of Positive Oxylanthanum Carbonate (OLC) Dose Escalation Data in Clinical and Translational Science

GlobeNewswire

6 months ago

Unicycive Therapeutics Announces Publication of Positive Oxylanthanum Carbonate (OLC) Dose Escalation Data in Clinical and Translational Science

Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics

GlobeNewswire

7 months ago

Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive Bioequivalence Data in Clinical Therapeutics

Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY)

Simply Wall St.

7 months ago

Breakeven On The Horizon For Unicycive Therapeutics, Inc. (NASDAQ:UNCY)

Unicycive Therapeutics to Participate in Two Upcoming Investor Conferences Including a Fireside Chat at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire

8 months ago

Unicycive Therapeutics to Participate in Two Upcoming Investor Conferences Including a Fireside Chat at the Piper Sandler 36th Annual Healthcare Conference

Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update

MT Newswires

8 months ago

Unicycive Therapeutics Says FDA Accepts New Drug Application for Oxylanthanum Carbonate

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

GlobeNewswire

8 months ago

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024

GlobeNewswire

8 months ago

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024

Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024

GlobeNewswire

9 months ago

Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024

Results of Phase I trial shed positive light on UNI-494 for acute kidney injury

Clinical Trials Arena

9 months ago

Results of Phase I trial shed positive light on UNI-494 for acute kidney injury

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024

GlobeNewswire

9 months ago

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024

Octagon Capital Advisors LP Acquires New Stake in Unicycive Therapeutics Inc

GuruFocus.com

9 months ago

Octagon Capital Advisors LP Acquires New Stake in Unicycive Therapeutics Inc

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers

GlobeNewswire

9 months ago

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers

Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024

GlobeNewswire

10 months ago

Unicycive Therapeutics to Participate in a Fireside Chat at the Virtual Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

GlobeNewswire

10 months ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

GlobeNewswire

10 months ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024

GlobeNewswire

10 months ago

Unicycive Therapeutics to Present at the Virtual Life Sciences Investor Forum on September 19, 2024

Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

10 months ago

Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

GlobeNewswire

10 months ago

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024

GlobeNewswire

a year ago

Unicycive Therapeutics to Present Three Posters at the American Society of Nephrology (ASN) Kidney Week 2024

Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth

Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update

MT Newswires

a year ago

Unicycive Therapeutics Receives US Patent for Potential Acute Kidney Treatment

Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)

GlobeNewswire

a year ago

Unicycive Therapeutics Granted Patent on UNI-494 to Treat Acute Kidney Injury by the United States Patent and Trademark Office (USPTO)

Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

GlobeNewswire

a year ago

Unicycive Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)

GlobeNewswire

a year ago

Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)

MT Newswires

a year ago

Unicycive Therapeutics Files Shelf Registration for Sale of Up to 50 Million Shares by Stockholders

Unicycive Therapeutics Joins Russell Microcap® Index

GlobeNewswire

a year ago

Unicycive Therapeutics Joins Russell Microcap® Index

Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial

GlobeNewswire

a year ago

Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial

When Can We Expect A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY)?

Simply Wall St.

a year ago

When Can We Expect A Profit From Unicycive Therapeutics, Inc. (NASDAQ:UNCY)?

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

GuruFocus.com

a year ago

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

GuruFocus.com

a year ago

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case

CNW Group

a year ago

Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress

GlobeNewswire

a year ago

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress

Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference

GlobeNewswire

a year ago

Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference

Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting

GlobeNewswire

a year ago

Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting

Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

TipRanks

a year ago

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

GlobeNewswire

a year ago

Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

GlobeNewswire

a year ago

Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress

Unicycive Announces $50 Million Private Placement

GlobeNewswire

a year ago

Unicycive Announces $50 Million Private Placement

Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference

GlobeNewswire

a year ago

Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference

Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)

GlobeNewswire

a year ago

Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)

Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients

GlobeNewswire

a year ago

Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients

Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting

GlobeNewswire

a year ago

Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting

We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate

Simply Wall St.

a year ago

We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate

Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference

GlobeNewswire

a year ago

Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference

Pathos AI Completes Acquisition of Rain Oncology

Business Wire

a year ago

Pathos AI Completes Acquisition of Rain Oncology

QuantaSing Group's (NASDAQ:QSG) Returns Have Hit A Wall

Simply Wall St.

a year ago

QuantaSing Group's (NASDAQ:QSG) Returns Have Hit A Wall

Unicycive (UNCY) Up on Positive Hyperphosphatemia Study Update

Zacks

a year ago

Unicycive (UNCY) Up on Positive Hyperphosphatemia Study Update

Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones

GlobeNewswire

a year ago

Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones

Lightbridge Announces Upcoming Industry Event and Media Interview

GlobeNewswire

a year ago

Lightbridge Announces Upcoming Industry Event and Media Interview

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why

Zacks

a year ago

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Business Wire

a year ago

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

LuxUrban Hotels to Present at Upcoming Investor Conferences

Business Wire

2 years ago

LuxUrban Hotels to Present at Upcoming Investor Conferences

Carbon Revolution plc Wheel Production More Than Tripled in Q4 CY2023 from Previous Year Quarter

GlobeNewswire

2 years ago

Carbon Revolution plc Wheel Production More Than Tripled in Q4 CY2023 from Previous Year Quarter

Electrovaya to Participate in the iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas Virtual Conference on January 9th and 10th, 2024

ACCESSWIRE

2 years ago

Electrovaya to Participate in the iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas Virtual Conference on January 9th and 10th, 2024

Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO

Zacks

2 years ago

Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO

ACCESSWIRE

2 years ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Burning Rock Announces Receipt of Notification from NASDAQ

GlobeNewswire

2 years ago

Burning Rock Announces Receipt of Notification from NASDAQ

Electrovaya Reports Record Revenue of $44.1 Million for Fiscal Year 2023; Up 171% Y/Y

ACCESSWIRE

2 years ago

Electrovaya Reports Record Revenue of $44.1 Million for Fiscal Year 2023; Up 171% Y/Y

iHuman Inc. Issues First Environmental, Social and Governance (ESG) Report

PR Newswire

2 years ago

iHuman Inc. Issues First Environmental, Social and Governance (ESG) Report

iHuman Inc. Announces Third Quarter 2023 Unaudited Financial Results

PR Newswire

2 years ago

iHuman Inc. Announces Third Quarter 2023 Unaudited Financial Results

Teekay Corporation's (NYSE:TK) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.

2 years ago

Teekay Corporation's (NYSE:TK) Stock Is Going Strong: Is the Market Following Fundamentals?

Burning Rock Announces Results of 2023 Annual General Meeting

GlobeNewswire

2 years ago

Burning Rock Announces Results of 2023 Annual General Meeting

Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis

GlobeNewswire

2 years ago

Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis

Share on Social Networks: